Trial description:
A Phase II Single-arm, Open-label Monotherapy Clinical Trial of Pembrolizumab (MK-3475) in Advanced Renal Cell Carcinoma (MK-3475-427)
Contact name:
Dr Kate Fife
Trial start date:
Thursday, February 23, 2017
Trial end date:
Monday, April 30, 2018
Trial tumour type:
Kidney
Show on Radiotherapy:
No
